Viridian Therapeutics Price Target Maintained With a $32.00/Share by Needham
Dow Jones Newswires
Viridian Therapeutics Price Target Maintained With a $32.00/Share by Needham
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:VRDN
- Language
- English